Raymond James & Associates »

Blueprint Medicines shares owned by Raymond James & Associates

Quarter-by-quarter ownership of Blueprint Medicines (BPMC) shares owned by Raymond James & Associates from 13F filings

Historical chart of Raymond James & Associates investment in Blueprint Medicines

Tip: Access up to 7 years of quarterly data

All positions including Blueprint Medicines held by Raymond James & Associates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Blueprint Medicines by Raymond James & Associates

Quarter filed Position value Share count Share price at filing
2024-03-31 $886k 9.3k 94.86
2023-12-31 $986k 11k 92.24
2023-09-30 $977k 19k 50.22
2023-06-30 $1.9M 30k 63.20
2023-03-31 $679k 15k 44.99
2022-12-31 $626k 14k 43.81
2022-09-30 $2.1M 31k 65.89
2022-06-30 $1.5M 29k 50.52
2022-03-31 $2.0M 32k 63.87
2021-12-31 $2.9M 27k 107.10
2021-09-30 $2.1M 20k 102.79
2021-06-30 $1.6M 18k 87.94
2021-03-31 $1.8M 18k 97.22
2020-12-31 $3.8M 34k 112.16
2020-09-30 $3.5M 38k 92.71
2020-06-30 $2.5M 32k 77.99
2020-03-31 $1.7M 30k 58.49
2019-12-31 $1.9M 24k 80.12
2019-09-30 $644k 8.8k 73.45
2019-06-30 $757k 8.0k 94.31
2019-03-31 $803k 10k 80.07
2018-12-31 $575k 11k 53.90
2018-09-30 $838k 11k 78.06
2018-03-31 $234k 2.6k 91.55
2017-12-31 $227k 3.0k 75.57
2017-09-30 $219k 3.1k 69.81